Hansen Medical (HNSN) 1.20 $HNSN
Hansen Medical (HNSN) in Focus: Stock Tumbles 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 32 mins ago
Hansen Medical has seen 1 negative revision in the past few weeks and its current year consensus loss estimate has widened over the last 30 days
Investors look to Lighten Up on Shares of Hansen Medical, Shares Down 8.2% (HNSN)
Comtex SmarTrend(R) - Mon May 12, 12:39PM CDT
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing low-priced stocks, down 8.2% to $1.18 on 2.2x average daily volume. Thus far today, Hansen Medical has traded 1.3 million shares, vs. average volume of 577,000 shares per day. The stock has underperformed the Dow (-8.2% to the Dow's 0.6%) and underperformed the S&P 500 (-8.2% to the S&P's 0.8%) during today's trading.
Hot Stock: Hansen Medical, Shares Drop 13.8% (HNSN)
Comtex SmarTrend(R) - Thu May 08, 10:11AM CDT
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing low-priced stocks, down 13.8% to $1.54 on 1.7x average daily volume. Thus far today, Hansen Medical has traded 867,000 shares, vs. average volume of 501,000 shares per day. The stock has underperformed the Dow (-13.8% to the Dow's 0.3%) and underperformed the S&P 500 (-13.8% to the S&P's 0.3%) during today's trading.
Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results
Marketwire - Wed May 07, 3:08PM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter of fiscal year 2014 ended March 31, 2014.
Hansen Medical Appoints Cary Vance as President and CEO
Marketwire - Wed May 07, 5:12AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that its Board of Directors has appointed industry veteran Cary Vance as the Company's President and Chief Executive Officer, and a member of the Board of Directors, effective as of May 23, 2014.
Semler Scientific, Inc. Appoints Medical Device and Pharmaceutical Industry Leader Bruce J Barclay to its Board of Directors
PR Newswire - Tue May 06, 3:30PM CDT
Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"
, an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services, today announced the appointment of Bruce J Barclay to the company's board of directors. Mr. Barclay will also chair the board's compensation committee and serve as a member of the audit committee. Mr. Barclay recently served as president and chief executive officer and board member of Hansen Medical, Inc. He has more than 15 years of experience in leading public and private companies in the medical device and pharmaceutical industries.
Hansen Medical's Sensei(R) X Robotic Catheter System to Be Featured at Heart Rhythm Society's 35th Annual Scientific Sessions
Marketwire - Mon May 05, 7:31AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Sensei(R) X Robotic Catheter System at the Heart Rhythm Society's (HRS) Annual Scientific Sessions from May 7 - 10 at the Moscone Center in San Francisco, California. Hansen will also reveal its new Sensei X2 Robotic System, which features faster processing, enhanced image integration and a slimmer design. The Sensei X2 is not yet commercially available in the U.S. or Europe. The Company will be conducting product demonstrations and displaying the Sensei Robotic System at Booth 620.
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
Hansen Medical Announces World's First Clinical Cases With New Magellan(TM) 6Fr Robotic Catheter
Marketwire - Tue Apr 29, 7:32AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), announced today the successful completion of the world's first clinical procedures using the Magellan(TM) 6Fr Robotic Catheter. Professor Marc Sapoval, MD, PhD and Dr. Olivier Pellerin, MD, MSc treated three patients with the 6Fr catheter over the span of two days at Hopital Europeen Georges Pompidou (APHP). The cases included two Uterine Fibroid Embolizations and a Transarterial Chemoembolization (TACE) procedure for liver metastasis of colon cancer.
Hansen Medical Announces 2014 First Quarter Results Conference Call
Marketwire - Fri Apr 25, 4:20PM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will release its financial and operating results for the first quarter ended March 31, 2014 after market close on Wednesday, May 7, 2014.
Will Obamacare Lead to a Medical Device Innovation Revolution?
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 13, 11:31AM CDT
The first year of Obamacare enrollment is officially in the books, and more than 7 million people enrolled for health insurance on a state or federally run Obamacare exchange. This figure more or less matches projected enrollment targets from the...
MediPoint: Electrophysiology - South America Analysis and Market Forecasts to 2020
M2 - Mon Apr 07, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rt6lxw/medipoint) has announced the addition of the "MediPoint: Electrophysiology - South America Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Training for EP device use is severely limited in Brazil, and although it has been improving over time, it is still not ideal. While manufacturers are willing to sell devices in Brazil, support for device use has been inadequate compared with the US or countries in Europe. As a result, many physicians learn as they go, developing the skills necessary to perform complex ablation from their experiences gained using the devices during simpler procedures. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/rt6lxw/medipoint
Hansen Medical's Magellan(TM) Robotic System to Be Featured at 36th Annual Charing Cross International Symposium
Marketwire - Thu Apr 03, 8:02AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 36th Annual Charing Cross International Symposium (CX 2014) from April 5 - 8 at Grand Hall Olympia in London, United Kingdom. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 221.
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
Medical Robots Market by Type & Application - Global Forecasts to 2018 for the $1,781 Million Market
M2 - Fri Mar 21, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwj8xd/medical_robots) has announced the addition of the "Medical Robots Market by Type (Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton) & Application (Orthopedic, Neurology, Laparoscopy)- Global Forecasts to 2018" report to their offering. The medical robotics market was valued at $1,781 million in 2013 and is expected to reach $3,764 million by 2018, growing at a CAGR of 16.1% from 2013 to 2018 Over the years, the demand for medical robots has increased significantly. This is due to the paradigm shift in the healthcare industry where emphasis is being laid on minimally invasive surgeries through the use of robots. The global medical robot market is categorized into five broad segments - surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and others. Based on applications, the medical robots market comprises the following segments - neurology, orthopedics, laparoscopy, special education, and other areas. . The hospital and pharmacy robots segment is the fastest-growing segment of the medical robotics market. The increasing demand for telemedicine robots is likely to propel the growth of this market. Along with this, technological developments and increasing adoption of newer technologies by hospitals are some factors that are propelling the demand for hospital and pharmacy robots. The other major segment under hospital and pharmacy robots is the i.v. robots segment. i.v. robots are dispensing robots used in hospitals and pharmacies to accurately compound drug mixtures. These robots are used to administer safe, accurate, efficient, cost-effective, and ready-to-administer IV admixtures. Factors such as an aging population, increasing spending power of the middle-class population, increasing number of private sector hospitals, advancements in endoscopic technologies, and expansions of rural healthcare facilities are also going to play a pivotal role in boosting the demand for medical robotics in the Asian region. China and Japan will be the focal point for the growth of medical robotics in the Asian market. Countries such as Singapore and Thailand are also expected to witness growth in this sector, owing to increasing government support. North America and Europe are both likely to witness an increasing demand for medical robotics owing to technological advancements as well as increased government support in both the geographies. Scope of the Report Segment - Surgical Robots -- Orthopedic Surgical Robots -- Neurological Surgical Systems -- Laparoscopy Robotic Systems -- Steerable Robotic Catheters - Rehabilitation Robots -- Assistive Robots -- Prosthetics -- Orthotics -- Therapeutic Robots -- Exoskeleton Robotic Systems - Non-Invasive Radio surgery Robots - Hospital and Pharmacy Robots -- Telemedicine Robots -- I.V. Robots -- Pharmacy Robots - Others Application - Neurology - Orthopedics - Laparoscopy - Special Education - Others Companies Mentioned - Accuray, Inc. - Hansen Medical, Inc. - Health Robotics S.R.L. - Intuitive Surgical Inc. - Mako Surgical Corp. - Mazor Robotics Ltd. - Medrobotics Corporation - Or Productivity Plc - Renishaw Plc - Titan Medical Inc. For more information visit http://www.researchandmarkets.com/research/mw...cal_robots
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Hansen Medical to Present Magellan(TM) Robotic System at the Society of Interventional Radiology's 39th Annual Scientific Meeting
Marketwire - Thu Mar 20, 8:20AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced it will present its Magellan(TM) Robotic System and its new 6Fr Robotic Catheter at the Society of Interventional Radiology's (SIR) Annual Scientific Meeting from March 23 - 27 at the San Diego Convention Center. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 800.
Hansen Medical to Present at the Inaugural BTIG Snowbird Medical Technology and Diagnostics Conference
Marketwire - Fri Mar 14, 8:01AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported that Peter J. Mariani, Chief Financial Officer, is scheduled to participate in meetings at the inaugural BTIG Snowbird Medical Technology and Diagnostics Conference on Tuesday and Wednesday, March 18 - 19, 2014. The conference is being held March 18 - 20, 2014 at The Cliff Lodge Hotel in Snowbird, Utah. The conference will consist of one-on-one meetings and will not be webcast.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
War On Poachers to Intensify
All Africa Global Media - Wed Feb 26, 12:31AM CST
THE government will use all resources at its disposal to improve anti-poaching operations and increase the number of game rangers to protect the country's wildlife from total extinction, Natural Resources and Tourism Minister Lazaro Nyalandu has said.
Hansen Medical (HNSN) in Focus: Stock Tumbles 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 32 mins ago
Hansen Medical has seen 1 negative revision in the past few weeks and its current year consensus loss estimate has widened over the last 30 days
Investors look to Lighten Up on Shares of Hansen Medical, Shares Down 8.2% (HNSN)
Comtex SmarTrend(R) - Mon May 12, 12:39PM CDT
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing low-priced stocks, down 8.2% to $1.18 on 2.2x average daily volume. Thus far today, Hansen Medical has traded 1.3 million shares, vs. average volume of 577,000 shares per day. The stock has underperformed the Dow (-8.2% to the Dow's 0.6%) and underperformed the S&P 500 (-8.2% to the S&P's 0.8%) during today's trading.
Hot Stock: Hansen Medical, Shares Drop 13.8% (HNSN)
Comtex SmarTrend(R) - Thu May 08, 10:11AM CDT
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing low-priced stocks, down 13.8% to $1.54 on 1.7x average daily volume. Thus far today, Hansen Medical has traded 867,000 shares, vs. average volume of 501,000 shares per day. The stock has underperformed the Dow (-13.8% to the Dow's 0.3%) and underperformed the S&P 500 (-13.8% to the S&P's 0.3%) during today's trading.
Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results
Marketwire - Wed May 07, 3:08PM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter of fiscal year 2014 ended March 31, 2014.
Hansen Medical Appoints Cary Vance as President and CEO
Marketwire - Wed May 07, 5:12AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that its Board of Directors has appointed industry veteran Cary Vance as the Company's President and Chief Executive Officer, and a member of the Board of Directors, effective as of May 23, 2014.
Semler Scientific, Inc. Appoints Medical Device and Pharmaceutical Industry Leader Bruce J Barclay to its Board of Directors
PR Newswire - Tue May 06, 3:30PM CDT
Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"
, an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services, today announced the appointment of Bruce J Barclay to the company's board of directors. Mr. Barclay will also chair the board's compensation committee and serve as a member of the audit committee. Mr. Barclay recently served as president and chief executive officer and board member of Hansen Medical, Inc. He has more than 15 years of experience in leading public and private companies in the medical device and pharmaceutical industries. Hansen Medical's Sensei(R) X Robotic Catheter System to Be Featured at Heart Rhythm Society's 35th Annual Scientific Sessions
Marketwire - Mon May 05, 7:31AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Sensei(R) X Robotic Catheter System at the Heart Rhythm Society's (HRS) Annual Scientific Sessions from May 7 - 10 at the Moscone Center in San Francisco, California. Hansen will also reveal its new Sensei X2 Robotic System, which features faster processing, enhanced image integration and a slimmer design. The Sensei X2 is not yet commercially available in the U.S. or Europe. The Company will be conducting product demonstrations and displaying the Sensei Robotic System at Booth 620.
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
Hansen Medical Announces World's First Clinical Cases With New Magellan(TM) 6Fr Robotic Catheter
Marketwire - Tue Apr 29, 7:32AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), announced today the successful completion of the world's first clinical procedures using the Magellan(TM) 6Fr Robotic Catheter. Professor Marc Sapoval, MD, PhD and Dr. Olivier Pellerin, MD, MSc treated three patients with the 6Fr catheter over the span of two days at Hopital Europeen Georges Pompidou (APHP). The cases included two Uterine Fibroid Embolizations and a Transarterial Chemoembolization (TACE) procedure for liver metastasis of colon cancer.
Hansen Medical Announces 2014 First Quarter Results Conference Call
Marketwire - Fri Apr 25, 4:20PM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will release its financial and operating results for the first quarter ended March 31, 2014 after market close on Wednesday, May 7, 2014.
Will Obamacare Lead to a Medical Device Innovation Revolution?
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 13, 11:31AM CDT
The first year of Obamacare enrollment is officially in the books, and more than 7 million people enrolled for health insurance on a state or federally run Obamacare exchange. This figure more or less matches projected enrollment targets from the...
MediPoint: Electrophysiology - South America Analysis and Market Forecasts to 2020
M2 - Mon Apr 07, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rt6lxw/medipoint) has announced the addition of the "MediPoint: Electrophysiology - South America Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Training for EP device use is severely limited in Brazil, and although it has been improving over time, it is still not ideal. While manufacturers are willing to sell devices in Brazil, support for device use has been inadequate compared with the US or countries in Europe. As a result, many physicians learn as they go, developing the skills necessary to perform complex ablation from their experiences gained using the devices during simpler procedures. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/rt6lxw/medipoint
Hansen Medical's Magellan(TM) Robotic System to Be Featured at 36th Annual Charing Cross International Symposium
Marketwire - Thu Apr 03, 8:02AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 36th Annual Charing Cross International Symposium (CX 2014) from April 5 - 8 at Grand Hall Olympia in London, United Kingdom. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 221.
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
Medical Robots Market by Type & Application - Global Forecasts to 2018 for the $1,781 Million Market
M2 - Fri Mar 21, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwj8xd/medical_robots) has announced the addition of the "Medical Robots Market by Type (Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton) & Application (Orthopedic, Neurology, Laparoscopy)- Global Forecasts to 2018" report to their offering. The medical robotics market was valued at $1,781 million in 2013 and is expected to reach $3,764 million by 2018, growing at a CAGR of 16.1% from 2013 to 2018 Over the years, the demand for medical robots has increased significantly. This is due to the paradigm shift in the healthcare industry where emphasis is being laid on minimally invasive surgeries through the use of robots. The global medical robot market is categorized into five broad segments - surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and others. Based on applications, the medical robots market comprises the following segments - neurology, orthopedics, laparoscopy, special education, and other areas. . The hospital and pharmacy robots segment is the fastest-growing segment of the medical robotics market. The increasing demand for telemedicine robots is likely to propel the growth of this market. Along with this, technological developments and increasing adoption of newer technologies by hospitals are some factors that are propelling the demand for hospital and pharmacy robots. The other major segment under hospital and pharmacy robots is the i.v. robots segment. i.v. robots are dispensing robots used in hospitals and pharmacies to accurately compound drug mixtures. These robots are used to administer safe, accurate, efficient, cost-effective, and ready-to-administer IV admixtures. Factors such as an aging population, increasing spending power of the middle-class population, increasing number of private sector hospitals, advancements in endoscopic technologies, and expansions of rural healthcare facilities are also going to play a pivotal role in boosting the demand for medical robotics in the Asian region. China and Japan will be the focal point for the growth of medical robotics in the Asian market. Countries such as Singapore and Thailand are also expected to witness growth in this sector, owing to increasing government support. North America and Europe are both likely to witness an increasing demand for medical robotics owing to technological advancements as well as increased government support in both the geographies. Scope of the Report Segment - Surgical Robots -- Orthopedic Surgical Robots -- Neurological Surgical Systems -- Laparoscopy Robotic Systems -- Steerable Robotic Catheters - Rehabilitation Robots -- Assistive Robots -- Prosthetics -- Orthotics -- Therapeutic Robots -- Exoskeleton Robotic Systems - Non-Invasive Radio surgery Robots - Hospital and Pharmacy Robots -- Telemedicine Robots -- I.V. Robots -- Pharmacy Robots - Others Application - Neurology - Orthopedics - Laparoscopy - Special Education - Others Companies Mentioned - Accuray, Inc. - Hansen Medical, Inc. - Health Robotics S.R.L. - Intuitive Surgical Inc. - Mako Surgical Corp. - Mazor Robotics Ltd. - Medrobotics Corporation - Or Productivity Plc - Renishaw Plc - Titan Medical Inc. For more information visit http://www.researchandmarkets.com/research/mw...cal_robots
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Hansen Medical to Present Magellan(TM) Robotic System at the Society of Interventional Radiology's 39th Annual Scientific Meeting
Marketwire - Thu Mar 20, 8:20AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced it will present its Magellan(TM) Robotic System and its new 6Fr Robotic Catheter at the Society of Interventional Radiology's (SIR) Annual Scientific Meeting from March 23 - 27 at the San Diego Convention Center. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 800.
Hansen Medical to Present at the Inaugural BTIG Snowbird Medical Technology and Diagnostics Conference
Marketwire - Fri Mar 14, 8:01AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported that Peter J. Mariani, Chief Financial Officer, is scheduled to participate in meetings at the inaugural BTIG Snowbird Medical Technology and Diagnostics Conference on Tuesday and Wednesday, March 18 - 19, 2014. The conference is being held March 18 - 20, 2014 at The Cliff Lodge Hotel in Snowbird, Utah. The conference will consist of one-on-one meetings and will not be webcast.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
War On Poachers to Intensify
All Africa Global Media - Wed Feb 26, 12:31AM CST
THE government will use all resources at its disposal to improve anti-poaching operations and increase the number of game rangers to protect the country's wildlife from total extinction, Natural Resources and Tourism Minister Lazaro Nyalandu has said.
